Cargando…
Seronegative Intestinal Villous Atrophy: A Diagnostic Challenge
Celiac disease is the most important cause of intestinal villous atrophy. Seronegative intestinal villous atrophy, including those that are nonresponsive to a gluten-free diet, is a diagnostic challenge. In these cases, before establishing the diagnosis of seronegative celiac disease, alternative et...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075602/ https://www.ncbi.nlm.nih.gov/pubmed/27803820 http://dx.doi.org/10.1155/2016/6392028 |
_version_ | 1782461893644910592 |
---|---|
author | Martins, Cláudio Teixeira, Cristina Ribeiro, Suzane Trabulo, Daniel Cardoso, Cláudia Mangualde, João Freire, Ricardo Alves, Ana Luísa Gamito, Élia Cremers, Isabelle Oliveira, Ana Paula |
author_facet | Martins, Cláudio Teixeira, Cristina Ribeiro, Suzane Trabulo, Daniel Cardoso, Cláudia Mangualde, João Freire, Ricardo Alves, Ana Luísa Gamito, Élia Cremers, Isabelle Oliveira, Ana Paula |
author_sort | Martins, Cláudio |
collection | PubMed |
description | Celiac disease is the most important cause of intestinal villous atrophy. Seronegative intestinal villous atrophy, including those that are nonresponsive to a gluten-free diet, is a diagnostic challenge. In these cases, before establishing the diagnosis of seronegative celiac disease, alternative etiologies of atrophic enteropathy should be considered. Recently, a new clinical entity responsible for seronegative villous atrophy was described—olmesartan-induced sprue-like enteropathy. Herein, we report two uncommon cases of atrophic enteropathy in patients with arterial hypertension under olmesartan, who presented with severe chronic diarrhea and significant involuntary weight loss. Further investigation revealed intestinal villous atrophy and intraepithelial lymphocytosis. Celiac disease and other causes of villous atrophy were ruled out. Drug-induced enteropathy was suspected and clinical improvement and histologic recovery were verified after olmesartan withdrawal. These cases highlight the importance for clinicians to maintain a high index of suspicion for olmesartan as a precipitant of sprue-like enteropathy. |
format | Online Article Text |
id | pubmed-5075602 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-50756022016-11-01 Seronegative Intestinal Villous Atrophy: A Diagnostic Challenge Martins, Cláudio Teixeira, Cristina Ribeiro, Suzane Trabulo, Daniel Cardoso, Cláudia Mangualde, João Freire, Ricardo Alves, Ana Luísa Gamito, Élia Cremers, Isabelle Oliveira, Ana Paula Case Rep Gastrointest Med Case Report Celiac disease is the most important cause of intestinal villous atrophy. Seronegative intestinal villous atrophy, including those that are nonresponsive to a gluten-free diet, is a diagnostic challenge. In these cases, before establishing the diagnosis of seronegative celiac disease, alternative etiologies of atrophic enteropathy should be considered. Recently, a new clinical entity responsible for seronegative villous atrophy was described—olmesartan-induced sprue-like enteropathy. Herein, we report two uncommon cases of atrophic enteropathy in patients with arterial hypertension under olmesartan, who presented with severe chronic diarrhea and significant involuntary weight loss. Further investigation revealed intestinal villous atrophy and intraepithelial lymphocytosis. Celiac disease and other causes of villous atrophy were ruled out. Drug-induced enteropathy was suspected and clinical improvement and histologic recovery were verified after olmesartan withdrawal. These cases highlight the importance for clinicians to maintain a high index of suspicion for olmesartan as a precipitant of sprue-like enteropathy. Hindawi Publishing Corporation 2016 2016-10-10 /pmc/articles/PMC5075602/ /pubmed/27803820 http://dx.doi.org/10.1155/2016/6392028 Text en Copyright © 2016 Cláudio Martins et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Martins, Cláudio Teixeira, Cristina Ribeiro, Suzane Trabulo, Daniel Cardoso, Cláudia Mangualde, João Freire, Ricardo Alves, Ana Luísa Gamito, Élia Cremers, Isabelle Oliveira, Ana Paula Seronegative Intestinal Villous Atrophy: A Diagnostic Challenge |
title | Seronegative Intestinal Villous Atrophy: A Diagnostic Challenge |
title_full | Seronegative Intestinal Villous Atrophy: A Diagnostic Challenge |
title_fullStr | Seronegative Intestinal Villous Atrophy: A Diagnostic Challenge |
title_full_unstemmed | Seronegative Intestinal Villous Atrophy: A Diagnostic Challenge |
title_short | Seronegative Intestinal Villous Atrophy: A Diagnostic Challenge |
title_sort | seronegative intestinal villous atrophy: a diagnostic challenge |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075602/ https://www.ncbi.nlm.nih.gov/pubmed/27803820 http://dx.doi.org/10.1155/2016/6392028 |
work_keys_str_mv | AT martinsclaudio seronegativeintestinalvillousatrophyadiagnosticchallenge AT teixeiracristina seronegativeintestinalvillousatrophyadiagnosticchallenge AT ribeirosuzane seronegativeintestinalvillousatrophyadiagnosticchallenge AT trabulodaniel seronegativeintestinalvillousatrophyadiagnosticchallenge AT cardosoclaudia seronegativeintestinalvillousatrophyadiagnosticchallenge AT mangualdejoao seronegativeintestinalvillousatrophyadiagnosticchallenge AT freirericardo seronegativeintestinalvillousatrophyadiagnosticchallenge AT alvesanaluisa seronegativeintestinalvillousatrophyadiagnosticchallenge AT gamitoelia seronegativeintestinalvillousatrophyadiagnosticchallenge AT cremersisabelle seronegativeintestinalvillousatrophyadiagnosticchallenge AT oliveiraanapaula seronegativeintestinalvillousatrophyadiagnosticchallenge |